Cantor Fitzgerald’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-361,583
Closed -$6.28M 461
2023
Q3
$6.28M Sell
361,583
-20,760
-5% -$433K 0.17% 161
2023
Q2
$7.96M Sell
382,343
-18,648
-5% -$405K 0.18% 165
2023
Q1
$9.43M Buy
400,991
+12,120
+3% +$325K 0.2% 171
2022
Q4
$10.9M Buy
388,871
+5,615
+1% +$144K 0.23% 148
2022
Q3
$8.97M Sell
383,256
-146,829
-28% -$4.43M 0.2% 160
2022
Q2
$17.9M Buy
+530,085
New +$18.6M 0.35% 84

Other funds holding OGN

Cantor Fitzgerald's OGN Position: Q4 2023 in Review

Cantor Fitzgerald sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 361,583 shares — an estimated $6.28M sold.

Cantor Fitzgerald first reported a position in OGN in Q2 2022 and held it in 6 quarters. The position peaked at $17.9M in Q2 2022. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Cantor Fitzgerald reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Cantor Fitzgerald sold 361,583 Organon & Co shares in Q4 2023, an estimated $6.28M.
  • Cantor Fitzgerald first reported a position in Organon & Co in Q2 2022 and held it in 6 quarters.
  • Cantor Fitzgerald's Organon & Co position peaked at $17.9M in Q2 2022.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Cantor Fitzgerald's 13F filing for Q4 2023, filed 14 Feb 2024.